Still's Disease & Macrophage Activation Syndrome

Systemic JIA: A Separate Entity?

Genetic architecture differs from other JIA subtypes

Treatment of adult-onset Still’s Disease

Treatment of adult-onset Still’s disease: a review Yvan Jamilloux,1–3,* Mathieu Gerfaud-Valentin,1,* Thomas Henry,3 Pascal Sève1 1Department of Internal Medicine, Hôpital de la Croix-Rousse, Université Claude Bernard-Lyon 1, Lyon,…|By Dove Press

Macrophage Activation Syndrome

Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic disease that,…

Interferon-γ (IFNγ) is the pivotal mediator in murine models of primary haemophagocytic lymphohistiocytosis (pHLH). Given the similarities between primary and secondary HLH (sec-HLH), including macrophage activation syndrome (MAS), we investigate the involvement of the IFNγ pathway in MAS by evaluat…